CIP
BNTX icon

Chartwell Investment Partners’s BioNTech BNTX Stock Holding History

Chartwell Investment Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,437
Closed -$553K – 412
2023
Q1 		$553K Buy
4,437
+8
+0.2% +$1.1K 0.02% 378
2022
Q4 		$665K Sell
4,429
-10
-0.2% -$1.54K 0.03% 372
2022
Q3 		$599K Sell
4,439
-38
-0.8% -$5.81K 0.03% 377
2022
Q2 		$668K Hold
4,477
– – 0.03% 381
2022
Q1 		$764K Sell
4,477
-1
-0% -$168 0.03% 393
2021
Q4 		$1.15M Sell
4,478
-14
-0.3% -$3.83K 0.03% 372
2021
Q3 		$1.23M Buy
+4,492
New +$1.43M 0.04% 360

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Chartwell Investment Partners's BNTX Position: Q2 2023 in Review

Chartwell Investment Partners sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 4,437 shares — an estimated $553K sold.

Chartwell Investment Partners first reported a position in BNTX in Q3 2021 and held it in 7 quarters. The position peaked at $1.23M in Q3 2021. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • Chartwell Investment Partners reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
  • Chartwell Investment Partners sold 4,437 BioNTech shares in Q2 2023, an estimated $553K.
  • Chartwell Investment Partners first reported a position in BioNTech in Q3 2021 and held it in 7 quarters.
  • Chartwell Investment Partners's BioNTech position peaked at $1.23M in Q3 2021.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Chartwell Investment Partners's 13F filing for Q2 2023, filed 25 Jul 2023.